1 / 13

ENABLING TRANSLATION INSTITUTE FOR CANCER/STEM CELL BIOLOGY AND MEDICINE

ENABLING TRANSLATION INSTITUTE FOR CANCER/STEM CELL BIOLOGY AND MEDICINE. Stanford School of Medicine Leadership Retreat January 29-31, 2004. Background. Created in December 2002 Purpose: To advance fundamental research in cancer and stem cell biology

Melvin
Download Presentation

ENABLING TRANSLATION INSTITUTE FOR CANCER/STEM CELL BIOLOGY AND MEDICINE

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. ENABLING TRANSLATION INSTITUTE FOR CANCER/STEM CELL BIOLOGY AND MEDICINE Stanford School of Medicine Leadership Retreat January 29-31, 2004

  2. Background • Created in December 2002 • Purpose: • To advance fundamental research in cancer and stem cell biology • To translate discoveries to preclinical paradigms • To organize efforts throughout the University • To enhance our understanding of human diseases • To improve patient care • Past Stanford-affiliated Accomplishments: • First prospective isolation of mouse hsc (1988) • First isolation of human hsc (1991) • First isolation of mouse and human hematopoietic progenitors (2000) • First prospectively isolated brain-forming (CNS) stem cells (2000) • Fruit fly sperm-forming stem cell identified (1999)

  3. Discovery => Translation => Therapy Example: Breast Cancer • Cancer-free human stem cells isolated and stored from patients with Stage IV breast cancer • Post-chemotherapy, stored hsc used to regenerate blood-forming system in patients • Blood-forming system regenerated in ≈ 2 weeks • Survival rates and cancer recurrence rates are much higher than expected from normal therapies • Future: Search for breast cancer stem cells, and define targets for diagnosis, molecular therapeutics, and immunotherapeutics by expression arrays and proteomics. • Similar experiences with non-Hodgkin’s Lymphomas

  4. Discovery => Translation => Therapy Promising Animal Models (at Stanford) for studying and using hematopoietic and CNS stem cells, and new tissue stem/progenitor cells: • Spinal Cord Injury, Cerebrovascular stroke • Genetic diseases leading to brain degeneration • Transplant Rejection improvements in • Heart Transplants • Pancreatic Insulin-Producing Islet Cells • Skin Grafts • Liver • Juvenile Type 1 diabetes • Infectious diseases of CNS (Arvin) and BMT (Brown)

  5. New Stem Cell Opportunities Through the Institute for Cancer/Stem Cell Biology and Medicine, we will: • Identify and recruit the best young stem cell biologists who wish to find new organ or tissue stem cells (lung, peripheral nervous system, skin, liver, pancreas, kidney, etc.) • Identify and appoint Associates and Affiliates. • Develop Affiliate ‘hotel’ space in CSCI to improve collaborations. • Establish research models to produce human pluripotent stem cells from patients with genetically determined diseases • Provide specialized research models and rigor to do it right the first time • Provide specialized instrumentation • Provide a vehicle for deeply-interested physicians, residents, graduate students, postdocs and, under the new curriculum, medical student scholars to form translational teams. • Establish educational programs for larger community.

  6. Comprehensive Cancer Center Role • Discovery of cancer stem cells and the protooncogenes activated in them is a convergence of: • Classic stem cell biologists • Classical cancer gene biologists • Cancer and Leukemia oncologists • Stanford approach to cancer and cancer stem cell biology: • Recruit 1 or more of the best cancer stem cell biologists in the world • Extend the tools of cancer stem cell biology to each of the cancers commonly treated at Stanford • Recruit to Stanford 1-2 of the best cancer gene biologists • Establish Stanford as an NCI-designated Comprehensive Cancer Center and recruit and outstanding leader

  7. The new Stanford Cancer Center, the Institute and NCI designation create a comprehensive approach to cancer: Stanford Hospital & Clinics & LPCH Clinical Care School of Medicine Research Institute for Cancer/Stem Cell Biology and Medicine Translational NCI-Designated Comprehensive Cancer Center Research

  8. Examples of Current Translational Collaborations NEW COLLABORATIVE RESEARCH PROGRAMS TO IDENTIFY AND ISOLATE HUMAN CANCER AND LEUKEMIA STEM CELLS • Brain Cancers: Griff Harsh, Steve Huehn, Steve Skirboll,Victor Tse, Sam Cheshier • Ovarian Cancers: Nelson Teng, Amreen Hussein • Lung Cancers: Glenn Rosen • Bladder, Prostate, and Kidney Cancers: Joe Presti, Linda Shortliffe • Uterine Cancers and Endometriosis: Linda Giudice • Acute and Chronic Myelogenous Leukemias: Catriona Jamieson, Robert Lowsky, Peter Greenberg • Breast Cancers: Matt van der Rijn, Michael Clarke (Michigan), Stephanie Jeffries, Jonathan Pollock • Head and Neck (tentative): Fee, Goode, Quynh-Thu Le

  9. Examples of Current Translational Collaborations COLLABORATIONS TO FIND TISSUE STEM CELLS • Pancreatic islets: Seung Kim and Roel Nusse • Cerebellum: Matt Scott • Bladder: Linda Shortliffe • Endometrium: Linda Giudice • Mesenchymal: Mike Longaker • Neural: Bill Mobley and Ann Arvin (ID) • Cardiac: Bobby Robbins • Hematopoietic progenitors: Wes Brown (ID)

  10. Examples of Current Translational Collaborations COLLABORATIONS TO FIND PROGENITOR CELLS IN THE IMMUNE SYSTEM • Dendritic cells: Ed Engleman and Miriam Merad • Precursor T cells: Sam Strober • Precursor B cells: Erik Ranheim • Marrow-engrafting facilitator cells: Judy Shizuru

  11. Current Translational Collaborations: Examples IMAGING AND EXPANDING BLOOD-FORMING STEM CELLS • Imaging: Chris Contag, Sam Gambhier • Expansion: Roel Nusse, Mark Kay

  12. Priority hires over next several years • Cancer Center Director (in progress) • Senior appointment in pluripotent stem cell biology (as soon as space is available) • Senior Cancer Stem Cell Physician Scientist (as soon as space is available) • Cancer gene scientist in collaboration with Cancer Center Director (in 1-3 years, if space is available) • Junior stem cell biologists (in 1-4 years as space becomes available); best possible at a fundamental level, but optimally in a field that can be translated

  13. Next Steps • Help raise funds for SIM 1 • Raise funds for CSCI recruitments, endowments, common core specialized instrumentation, funding for ‘hotel space’ labs in CSCI. • Recruitments as detailed. • With Steering Committee, begin process of identifying internal candidates for Associate positions in CSCI. • With Steering Committee canvas current university faculty for Affiliate positions in CSCI, and choose affiliates.

More Related